NeuroSense Therapeutics Ltd. Payments to Acquire Other Receivables
NeuroSense Therapeutics Ltd. (NRSN) reported Payments to Acquire Other Receivables of $3.00 thousand for the 12-month period ending 2023-12-31, per its 6-K filed 2024-06-17.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherReceivables · last filed 2024-06-17
| Period end | Payments to Acquire Other Receivables 12 month |
|---|---|
| 2023-12-31 | $3.00K 6-K · filed 2024-06-17 |
| 2022-12-31 | $20.00K 6-K · filed 2024-06-17 |